Víctor Urrea Gales
Víctor Urrea Gales was awarded an MSc in Statistics and Operations Research by the Technical University of Catalonia (UPC) in 2009 and a PhD in Systems Biology by the University of Vic (UVic) in 2015. His research focuses on the development of new methods to study genetic interactions, the identification of genetic risk profiles and the construction of disease prediction and prognostic models. Employed as a statistician at IrsiCaixa, he assists in the analysis of experimental and clinical trial data.
Immunization with V987H-stabilized Spike glycoprotein protects K18-hACE2 mice and golden Syrian hamsters upon SARS-CoV-2 infection.
A monoclonal antibody targeting a large surface of the receptor binding motif shows pan-neutralizing SARS-CoV-2 activity.
Virus-like particle-mediated delivery of structure-selected neoantigens demonstrates immunogenicity and antitumoral activity in mice.
Alanine-based spacers promote an efficient antigen processing and presentation in neoantigen polypeptide vaccines.
Impact of obefazimod on viral persistence, inflammation, and immune activation in people with HIV on suppressive antiretroviral therapy.